Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Fibrinolítico")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 7025

  • Page / 281
Export

Selection :

  • and

Thrombolytic therapy: current status. (first of two parts)MARDER, V. J; SHERRY, S.The New England journal of medicine. 1988, Vol 318, Num 23, pp 1512-1520, issn 0028-4793Article

Antistreptokinase titres after intravenous streptokinaseJALIHAL, S; MORRIS, G. K.Lancet (British edition). 1990, Vol 335, Num 8683, pp 184-185, issn 0140-6736, 2 p.Article

Effects of Thrombolytic Agents on Tympanostomy Tubes Occluded by Blood ClotsORESTES, Michael I; FILETA, Bader; HAYMES, Snezana et al.Archives of otolaryngology, head & neck surgery. 2011, Vol 137, Num 12, pp 1228-1231, issn 0886-4470, 4 p.Article

Thrombolytic therapy in a community hospitalSPITZER, S; CARVER, J. R; PARRIS, T. M et al.Practical cardiology. 1991, Vol 17, Num 2, pp 48-50, issn 0361-3372, 3 p.Article

In Vitro Inhibition of Factor XIII Retards Clot Formation, Reduces Clot Firmness, and Increases Fibrinolytic Effects in Whole BloodJAMBOR, Csilla; REUL, Viviane; SCHNIDER, Thomas W et al.Anesthesia and analgesia. 2009, Vol 109, Num 4, pp 1023-1028, issn 0003-2999, 6 p.Article

Des microparticules cellulaires dévoilent leur fonction fibrinolytique et protéolytique = Cell-derived microparticles unveil their fibrinolytic and proteolytic functionDOEUVRE, Loïc; ANGLES-CANO, Eduardo.MS. Médecine sciences. 2009, Vol 25, Num 1, pp 37-44, issn 0767-0974, 8 p.Article

Induction of a sustained fibrinolytic response by BRL 26921 in vitroFEARS, R; GREEN, J; SMITH, R. A. G et al.Thrombosis research. 1985, Vol 38, Num 3, pp 251-260, issn 0049-3848Article

Pharmacokinetics and systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator (rt-PA) in humansVERSTRAETE, M; BOUNAMEAUX, H; DE COCK, F et al.The Journal of pharmacology and experimental therapeutics. 1985, Vol 235, Num 2, pp 506-512, issn 0022-3565Article

Use of streptokinase for the salvage of a free flap: case report and review of the use of thrombolytic therapyCHUBERT, W; HUNTER, D. W; GUZMAN-STEIN, G et al.Microsurgery. 1987, Vol 8, Num 3, pp 117-121, issn 0738-1085Article

Clinical experience with tissue plasminogen activator stored at -20°CGREWING, R; MESTER, U; LÖW, M et al.Ophthalmic surgery. 1992, Vol 23, Num 11, pp 780-781, issn 0022-023XArticle

Ancrod causes rapid thrombolysis in patients with acute strokePOLLAK, V. E; GLAS-GREENWALT, P; OLINGER, C. P et al.The American journal of the medical sciences. 1990, Vol 299, Num 5, pp 319-325, issn 0002-9629Article

Rise of plasma t-PA fibrinolytic activity in a group of maturity onset diabetic patients shifted from a first generation (tolbutamide) to a second generation sulphonylurea (gliclazide)GRAM, J; KOLD, A; JESPERSEN, J et al.Journal of internal medicine. 1989, Vol 225, Num 4, pp 241-247, issn 0954-6820, 7 p.Article

Rationale for the development of antithrombotic, antimetastatic and fibrinolytic durgs: a mechanic point of view, international workshop, Montebello PQ, Canada, April 28-May 1, 1987BASTIDA, E. Ed; BUCHANAN, M. R; OFOSU, F. A et al.Seminars in thrombosis and hemostasis. 1988, Vol 14, Num 1, pp 1-132, issn 0094-6176Conference Proceedings

Les fibrinolytiques : Evolution et applications actuelles = Thrombolytic therapyDAVID, J. L.RMLG. Revue médicale de Liège. 1996, Vol 51, Num 1, pp 35-43, issn 0370-629XArticle

Thrombolytic agentsTHOMPSON, P. L.Medical journal of Australia. 1994, Vol 160, Num 1, pp 29-32, issn 0025-729XArticle

Pharmacologie générale du plasminogen activator tissulaire (AK-124)FUJII, M.Yakuri to chiryo. 1988, Vol 16, Num 8, pp 13-31, issn 0386-3603Article

Mécanisme thrombolytique du plasminogen pro-activatorKASAI, S.Yakuri to chiryo. 1987, Vol 15, Num 11, pp 395-403, issn 0386-3603Article

The hematologic consequences of thrombolytic therapyFLETCHER, A. P; ALKJAERSIG, N. K.Progress in hematology. 1986, Vol 14, pp 183-200, issn 0079-6301Article

The fibrinolytic action of flufenamate and its influence on plasminogen binding to fibrinCHEVALLET-PRANDINI, M. H; CHAPEL, A; SUSCILLON, M et al.Thrombosis research. 1985, Vol 38, Num 5, pp 481-489, issn 0049-3848Article

Thrombolytic therapy in the eightiesVERSTRAETE, M; COLLEN, D.Blood. 1986, Vol 67, Num 6, pp 1529-1541, issn 0006-4971Article

Thrombolytic agents in developmentVERSTRAETE, M; LIJNEN, H. R; COLLEN, D et al.Drugs (Basel). 1995, Vol 50, Num 1, pp 29-42, issn 0012-6667Article

Fibrinolytic therapy : biochemical mechanismsROBBINS, K. C.Seminars in thrombosis and hemostasis. 1991, Vol 17, Num 1, pp 1-6, issn 0094-6176Article

Tissue-type plasminogen activator mutants: theoretical and clinical considerationsBANG, N. U.Circulation (New York, N.Y.). 1989, Vol 79, Num 6, pp 1391-1392, issn 0009-7322Article

Mafenide (sulfamylonTM) inhibits plasmin fibrinolytic activityWEISDORF, D. J; ALDRIDGE, J. H.Thrombosis and haemostasis. 1988, Vol 59, Num 3, pp 440-444, issn 0340-6245Article

Successful thrombolytic therapy for stuck mitral mechanical valveOBIED, Hamoud Y; IBRAHIM, Mohammed F; LATROCHE, Bendehiba S et al.Saudi medical journal. 2009, Vol 30, Num 7, pp 964-966, issn 0379-5284, 3 p.Article

  • Page / 281